Drs. Remo Rohs (PI, left) and Steve Kay (co-PI, right) received an SBIR/STTR planning grant, "AI-driven discovery of novel BMAL1 modulators for the treatment of Circadian dysregulation and cancer", from the Office of Research and Innovation. A goal of this award is the commercialization of the AI-based design of drug-like molecules and their validation. This work is led by Jesse Weller, a Ph.D. student in the Rohs Lab.
top of page
bottom of page
Commentaires